Additionally, identifying the ubiquitin ligases and DUBs that act on differentially phosphorylated LRRK2 will further elaborate on the mechanisms of its regulation and could serve as novel targets for PD drug discovery. This evidence concerns the gene LRRK2 and Parkinson disease.